Individual and system level factors associated with treatment nonadherence in human immunodeficiency virus-infected men and women

被引:83
|
作者
Van Servellen, G
Chang, B
Garcia, L
Lombardi, E
机构
[1] Univ Calif Los Angeles, Sch Nursing, Acute Care Sect, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Integrated Subst Abuse Programs, Los Angeles, CA 90095 USA
关键词
D O I
10.1089/10872910260066705
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Antiretroviral treatment nonadherence is complex, implicating more than a patient's ability and motivation to be compliant. The bulk of the research to date focuses on individual level barriers with less emphasis on the many system level factors that potentially impact patients' adherence behaviors. This study examined the effects of system enabling factors in addition to the frequently studied individual predisposing and enabling factors upon nonadherence to treatment. One hundred eighty-two patients from five community-based clinics were interviewed and their medical charts examined. Patients' self-reported nonadherence was correlated with clinicians' assessments of medication and appointment nonadherence. Seven individual predisposing factors (gender, ethnicity, birthplace, years of education, HIV Overview of Problems-Evaluation System [HOPES] psychosocial, Hospital Anxiety and Depression Scale [HADS] anxiety, and HADS depression scores) were found to be significantly associated with treatment adherence/nonadherence. Individual enabling factors (hopefulness and access to health care), as well as treatment by clinic staff, a system enabling factor, were significantly associated with adherence/nonadherence. In a multivariate analysis, six factors-age (younger), gender (female), birth outside the United States, level of hopefulness (lower), access to health care (lower), and treatment by clinic staff (poorer)-accounted for 19.3% of the variance in nonadherence. Results of this study indicated that several individual predisposing and enabling factors were potential predictors of treatment nonadherence; however, system enabling factors, e. g., treatment by clinic staff were also associated with treatment nonadherence. Further studies are needed to examine the complex relationships of individual and system related factors in predicting treatment nonadherence.
引用
收藏
页码:269 / 281
页数:13
相关论文
共 50 条
  • [21] Bipolar herpes simplex infection in an human immunodeficiency virus-infected individual
    Raghukumar, Sonia
    Ravikumar, C. B.
    INDIAN JOURNAL OF SEXUALLY TRANSMITTED DISEASES AND AIDS, 2021, 42 (01) : 72 - +
  • [22] An Unusual Pathogen for a Liver Abscess in a Human Immunodeficiency Virus-Infected Individual
    Sayana, Shilpa
    Ricaurte, Juan-Carlos
    Khanlou, Homayoon
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 339 (03): : 290 - 291
  • [23] The human immunodeficiency virus-infected traveler
    Castelli, F
    Patroni, A
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (06) : 1403 - 1408
  • [24] Low bone mass in human immunodeficiency virus-infected climacteric women receiving antiretroviral therapy: prevalence and associated factors
    Gomes, Debora C.
    Valadares, Ana L. R.
    de Moraes, Monica J.
    Lagrutta, Bianca B.
    Pinto-Neto, Aarao M.
    Costa-Paiva, Lucia
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (02): : 224 - 230
  • [25] Factors Associated With Precancerous Cervical Lesions in Human Immunodeficiency Virus-Infected Women: A Cross-Sectional Survey in Togo
    Darre, Tchin
    Djiwa, Toukilnan
    Ladekpo, Karell Josiane Ogniade
    M'Bortche, Bingo K.
    Douaguibe, Baguilane
    Aboubakari, Abdoul-Samadou
    Ekouevi, Didier Koumavi
    Saka, Bayaki
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2024, 18
  • [26] Sexual Behaviors of Human Immunodeficiency Virus-Infected Pregnant Women and Factors Associated With Sexually Transmitted Infection in South Africa
    Davey, Dvora Joseph
    Peters, Remco P. H.
    Kojima, Noah
    Mudau, Maanda
    De Vos, Lindsey
    Olivier, Dawie
    McIntyre, James A.
    Klausner, Jeffrey D.
    Medina-Marino, Andrew
    SEXUALLY TRANSMITTED DISEASES, 2018, 45 (11) : 754 - 761
  • [27] THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH INTRAVENOUS IMMUNOGLOBULIN
    YAP, PL
    WILLIAMS, PE
    JOURNAL OF HOSPITAL INFECTION, 1988, 12 : 35 - 46
  • [28] Associated factors with syphilis among human immunodeficiency virus-infected men who have sex with men in Taiwan in the era of combination antiretroviral therapy
    Chang, Yi-Hsin
    Liu, Wen-Chun
    Chang, Sui-Yuan
    Wu, Bing-Ru
    Wu, Pei-Ying
    Tsai, Mao-Song
    Hung, Chien-Ching
    Lew-Ting, Chih-Yin
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2014, 47 (06) : 533 - 541
  • [29] Relationship of pregnancy to human papillornavirus among human immunodeficiency virus-infected women
    Minkoff, Howard
    Xian, Lin Shen
    Watts, D. Heather
    Leighty, Robert
    Hershow, Ron
    Palefsky, Joel
    Tuomala, Ruth
    Neu, Natalie
    Zorrilla, Carmen D.
    Paul, Mary
    Strickler, Howard
    OBSTETRICS AND GYNECOLOGY, 2006, 108 (04): : 953 - 960
  • [30] Safety and Efficacy of Fosamprenavir in Human Immunodeficiency Virus-infected Pregnant Women
    Martorell, Claudia
    Theroux, Eileen
    Bermudez, Arlene
    Garb, Jane
    Kronschnabel, Debra
    Oie, Katrina
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (10) : 985 - 985